How is the ovarian PRP rejuvenation procedure performed?
The process of ovarian PRP rejuvenation involves two steps. The first is the preparation of your PRP. This begins with at the insertion of a needle into your vein in order to obtain several tubes of your blood. Your white blood cells and platelets are separated from the red blood cells and serum by a procedure called centrifugation. The preparation of your PRP takes less than one hour. The next part of the ovarian PRP rejuvenation process is the injection of the PRP into the ovaries. The major difference in our study and the technique described in the referenced case study is that we use a non-surgical approach to the ovarian injections. The technique that we have developed to inject the cells into the ovaries is a nonsurgical, transvaginal ultrasound- guided injection performed under sedation with an anesthetic agent called Propofol. This is basically the same as the procedure that is used for an egg retrieval in the IVF. In our experience, our approach is less invasive, safer, and has a shorter, more comfortable recovery.
What are the potential risks and benefits of the procedure?
The benefit of this procedure is the possibility of achieving pregnancy with one’s own eggs, which had not been possible prior to this procedure. Since this is an innovative medical treatment, it must be understood that there is no guarantee, stated or implied, that pregnancy, either naturally, or as a result of any subsequent fertility procedure, will occur. The risks of this procedure are minimal, and are basically the same as those for an egg retrieval procedure. The possible side effects are pain after the procedure, which usually resolves in 1-2 hours with pain medication, fever or internal bleeding.
Who are candidates for this procedure?
Menopausal or perimenopausal women under the age of 50 years.
Infertile women, over the age of 35 years, having low egg reserve and low AntiMullerian Hormone levels.
Women under the age of 35 years, who have low egg reserve and low AntiMullerian Hormone levels.
Women with premature ovarian failure (POF).